A person might feel hungry again three hours later
Established Multi-Receptor Options# All approved and late-stage dual and triple agonists are injectable: tirzepatide (GIP/GLP-1), retatrutide (GIP/GLP-1/glucagon), CagriSema (amylin/GLP-1), and survodutide (GLP-1/glucagon)
"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,
This is the nearest human data in the class, and it was negative which is context for efficacy, not evidence that Dihexa is unsafe or safe
Nersessian RS, da Silva LM, Carvalho MA, Silveira SQ, Abib AC, Bellicieri FN, et al